Actualités 30. Apr. 2024 Les Grands Titres de Suisse occidentale (Avril 2024) De percées biotechnologiques à la transformation des essais cliniques, en passant par des avancées dans le domaine des matériaux écologiques et d...
News 30. Apr. 2024 Top Stories from Western Switzerland (April 2024) From biotech breakthroughs and the transformation of clinical trials to advancements in eco-friendly materials and renewable energy initiatives, ...
Aktuell 06. Mai 2024 EY meldet Plus von 53 Prozent bei Investitionen in der Schweiz Ausländische Investitionen in Europa sind 2023 um 4 Prozent gesunken. Die Investitionen in der Schweiz sind dagegen um 53 Prozent gestiegen. Das ...
News 06. Mai 2024 EY reports growth of 53 percent for investments in Switzerland Foreign investments in Europe fell by 4 percent in 2023. However, investments in Switzerland were up by 53 percent. These findings were reported ...
News 10. Jan. 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 29. Sep 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News 14. Aug. 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
Actualités 10. Jan. 2024 L’essor remarquable de la chimie-pharma dans le canton du Valais Depuis des décennies, le canton du Valais a cultivé une réputation d’excellente dans les domaines de la chimie et de la pharmaceutique, fusionnan...
News 19. Okt. 2021 Loop Medical raises USD 6.4 million to conquer US market Vaud-based healthcare start-up Loop Medical has completed a USD 6.4 million Series A financing round for its innovative blood collection device.
News 08. März 2023 Oculis lists on Nasdaq with strong clinical-stage pipeline in ophthalmology Oculis Holding AG, a global biopharmaceutical company focused on saving sight and improving eye care, has announced its listing on the Nasdaq sto...
Actualités 29. Sep 2023 Les Grands Titres de Suisse occidentale (Juillet-Septembre 2023) De l'élaboration de solutions éco-innovantes à des avancées pionnières dans les domaines de la technologie solaire, de la recherche sur le cancer...
Actualités 14. Aug. 2023 L’écosystème florissant de Berne pour l’innovation en sciences de la vie Au cœur de la Suisse occidentale, le canton de Berne s'est imposé comme une destination de choix pour les entreprises du secteur des sciences de ...
News 18. Jan. 2023 Calciscon enters Eurostars project to improve patient care worldwide Calciscon, together with Amsterdam University Medical Centers and ADMESY, have signed a collaborative agreement for the development of a laborato...
News 23. Nov. 2022 Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million Women's and reproductive health specialist ObsEva has announced the sale of its license for ebopiprant to California-based biotech company Xoma f...
News 22. Febr. 2022 Digital neurotherapeutics specialist MindMaze secures USD 105 million MindMaze has closed a USD 105 million financing round to accelerate its global commercial growth plans, supercharge ongoing R&D and consolidate t...
News 12. Okt. 2021 Neurotherapeutics pioneer MindMaze secures USD 125 million MindMaze, a global pioneer in the digital neurotherapeutics market, raised USD 125 million from AlbaCore Capital Group. This brings the Vaud-base...
Actualités 08. März 2023 Oculis fait son entrée au Nasdaq avec un pipeline prometteur en ophtalmologie Oculis Holding AG, une société biopharmaceutique internationale dont l’objectif est de préserver la vue et d’améliorer les soins oculaires, a ann...
News 06. Okt. 2020 SOPHiA GENETICS raises $110 million Global leader in data-driven medicine SOPHiA GENETICS has closed a $110 million financing round to enter the next stage of its expansion, with a ...